Document is current
Any future updates will be listed below
-
Authors
Ghadimi, Mahnaz
Foroughi, Farshad
Hashemipour, Sima
Nooshabadi, Mohammadreza Rashidi
Ahmadi, Mohammad Hossein
Yari, Mojtaba Ghadimi
Kavianpour, Maria
Haghighian, Hossein Khadem http://orcid.org/0000-0002-7445-1846
-
Clinical Trials BETA
Clinical trials referenced in this document:
irct20141025019669n13 at Iranian Registry of Clinical TrialsDocuments that mention this clinical trial
Decreased insulin resistance in diabetic patients by influencing Sirtuin1 and Fetuin-A following supplementation with ellagic acid: a randomized controlled trial
https://doi.org/10.1186/s13098-021-00633-8
-
Funding
Funding for this research was provided by:
Qazvin University of Medical Sciences (IR.QUMS.REC.1398.079)
- License Information
-
More Information
Article History
Received: 2 November 2020
Accepted: 22 January 2021
First Online: 5 February 2021
Ethics approval and consent to participate
: We confirm that any aspect of the work covered in this manuscript that has involved either human patient has been conducted with the ethical approval of all relevant bodies, in Ethical committee of Qazvin University of Medical Science, Qazvin, Iran by grant number of IR.QUMS.REC.1398.079. On the other hand, the protocol was registered in IRCT by the number IRCT20141025019669N13. All the eligible and volunteered subjects had been written consent for supplementary care before research.
: Not applicable.
: The authors declare that they have no competing interests.
